• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurv. Increased incidence of Mycoplasma pneumoniae infections and hospital admissions in the Netherlands, November to December 2023

tetano

Editor, Senior Moderator
Dita C Bolluyt[SUP]1[/SUP] , Sjoerd M Euser[SUP]2,*[/SUP] , Dennis Souverein[SUP]2,*[/SUP] , Annemarie MC van Rossum[SUP]3[/SUP] , Jayant Kalpoe[SUP]2[/SUP] , Mireille van Westreenen[SUP]4[/SUP] , Marco Goeijenbier[SUP]5,6[/SUP] , Dominic Snijders[SUP]7[/SUP] , Dirk Eggink[SUP]8[/SUP] , Femke Jongenotter[SUP]8[/SUP] , Steven FL van Lelyveld[SUP]1,*[/SUP] , Marlies A van Houten[SUP]9,[/SUP]​

Mycoplasma pneumoniae is an important cause of pneumonia and extra-pulmonary manifestations. We observed a rise in admissions due to M. pneumoniae infections starting October 2023 in a regional hospital in the Netherlands and an increased incidence in national surveillance data. The incidence in the Netherlands has not been that high since 2011. The patients had a lower median age compared with 2019 and 2020 (28 vs 40 years). M. pneumoniae should be considered in patients with respiratory symptoms, especially children.​

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2024.29.4.2300724#html_fulltext
 
Back
Top Bottom